首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized double‐blind crossover trial

【2h】

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized double‐blind crossover trial

机译：连续皮下注射胰岛素的1型糖尿病患者速效门冬胰岛素与门冬胰岛素的药理特性：一项随机双盲交叉试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimTo evaluate the pharmacological characteristics of faster‐acting insulin aspart (faster aspart) compared with insulin aspart (IAsp) during continuous subcutaneous insulin infusion (CSII).

机译：目的评估连续皮下胰岛素输注（CSII）过程中速效天冬胰岛素（更快的天冬氨酸）与天冬胰岛素（IAsp）的药理特性。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Tim Heise; Eric Zijlstra; Leszek Nosek; Tord Rikte; Hanne Haahr;
展开▼
作者单位

展开▼
年(卷),期 -1(19),2
年度 -1
页码 208–215
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
insulin pump therapy pharmacodynamics pharmacokinetics type 1 diabetes;

机译：胰岛素泵治疗;药效学;药代动力学;1型糖尿病;

相似文献

外文文献
中文文献
专利

1. Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial [J] . Heise Tim, Zijlstra Eric, Nosek Leszek, Diabetes, obesity & metabolism . 2017,第2期

机译：1型糖尿病患者患者的胰岛素胰岛素Aspart的药理性质，接受连续皮下胰岛素输注：随机，双盲，交叉试验
2. INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART [J] . Thrasher James, Bhargava Anuj, Rees Tina M., Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2015,第3期

机译：连续皮下注射胰岛素的胰岛素替代品在2型糖尿病患者中是安全有效的：胰岛素替代品与胰岛素ASPART的随机交叉试验
3. Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial [J] . Buse John B., Carlson Anders L., Komatsu Mitsuhisa, Diabetes, obesity & metabolism . 2018,第12期

机译：快速作用的胰岛素Aspart与胰岛素Aspart在胰岛素Degludec治疗的1型糖尿病中：随机双盲试验中的功效和安全性
4. PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF INSULIN ASPART FOLLOWING SUBCUTANEOUS AND INTRAMUSCULAR INJECTION IN CATS [C] . Hannah Pipe-Martin, Jon Fletcher, Chen Gilor, Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：胰岛素肌肉内注射后胰岛素Aspart的药物动力学和药代动力学特性
5. Evaluating Hypoglycemic Risk of Two Basal Insulin Delivery Methods for Type 1 Diabetes: A Comparison of Tresiba Insulin Against Continuous Subcutaneous Insulin Infusion Using Data from Continuous Glucose Monitors [D] . Lane, Benjamin. 2020

机译：评估1型糖尿病两种基础胰岛素递送方法的低血糖风险：使用来自连续葡萄糖监测器的数据进行TRESIBA胰岛素对连续皮下胰岛素输注的比较
6. Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial [O] . John B. Buse, Anders L. Carlson, Mitsuhisa Komatsu, -1

机译：快速地门冬胰岛素和门冬胰岛素在以地格曲酮治疗的1型糖尿病中的作用：一项随机双盲试验的疗效和安全性
7. Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus [O] . Hanne Haahr, Thomas R. Pieber, Chantal Mathieu, 2018

机译：快速胰岛素Aspart的临床药理学与胰岛素Aspart测量的胰岛素Aspart，以及与1型糖尿病的受试者抗胰岛素Aspart抗体水平的关系

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized double‐blind crossover trial

摘要

著录项

相似文献

相关主题

期刊订阅